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DObjective: We sought to evaluate pulmonary artery banding in infants with complete atrioventricular septal
defects.
Methods: From 2000 to 2009, 20 infants with complete atrioventricular septal defects underwent pulmonary ar-
tery banding because of unsuitable anatomy (unbalanced ventricles, associated lesions, or both) or clinical con-
dition (infection, chronic lung disease, or noncardiac malformation). Patients were divided into 2 groups: the
conventional PAB group (n ¼ 13 [65%]; mean age, 74  56 days [range, 6–187 days]; mean weight, 3.3 
1.1 kg [range, 2.1–5.8 kg]) and the FloWatch-PAB group (n ¼ 7 [35%]; mean age, 111  40 days [range,
81–187 days]; mean weight, 4.3  1.2 kg [range, 3.2–6.1 kg]). There was no statistical difference in age or
weight. Preoperative mechanical ventilation was required in 3 (23%) of 13 infants in the conventional PAB group
and 5 (71%) of 7 infants in the FloWatch-PAB group (P< .05).
Results: Ten (77%) of 13 infants in the conventional PAB group died versus 0 (0%) of 7 infants in the
FloWatch-PAB group (P< .001). Sternal closure was delayed in 6 (46%) of 13 infants in the conventional
PAB group and 0 (0%) of 7 infants in the FloWatch-PAB group (P< .05). The mean duration of mechanical
ventilation, intensive care unit stay, and hospital stay was significantly longer (P<.05) in the conventional PAB
group than in the FloWatch-PAB group (21  17 days [range, 4–61 days] vs 3  2 days [range, 1–8 days], 22 
18 days [range, 5–61 days] vs 7  6 days [range, 2–21 days], and 54  12 days [range, 40–71 days] vs 29  25
days [range, 9–81 days], respectively). Left atrioventricular valve regurgitation increased (mild to moderate) in 2
infants in the conventional PAB group and decreased (severe to moderate) in 2 infants in the FloWatch-PAB
group. Six of 10 survivors (1 in the conventional PAB group and 5 in the FloWatch-PAB group) underwent
pulmonary artery debanding and repair after a median interval of 125 days (range, 34–871 days); 4 of 10 are
awaiting repair.
Conclusions: In selected patients with complete atrioventricular septal defects, pulmonary artery banding fol-
lowed by late repair is a viable alternative strategy. In our study the FloWatch-PAB device resulted in improved
survival and made later repair possible in a better clinical state. (J Thorac Cardiovasc Surg 2011;141:179-82)Primary repair is now the treatment of choice for infants with
complete atrioventricular septal defects (cAVSDs) to prevent
irreversible pulmonary hypertension. Because thickening of
the media of the small pulmonary arteries can occur by 6
months of age, primary repair is generally performed before
this time to prevent pulmonary vascular obstructive disease.1
Various reports have demonstrated safe and effective repair in
infants with cAVSDs within the first few months of life.2-8e Cardiac Unit, Alder Hey Children NHS Foundation Trust, Liverpool, United
dom.
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The Journal of Thoracic and CaSome children with cAVSDs are not suitable for early pri-
mary repair. Reasons include (1) unfavorable intracardiac
anatomy, such as unbalanced ventricular morphology; (2)
associated noncardiac anomalies, such as exomphalos; (3)
poor clinical status contraindicating cardiopulmonary by-
pass because of active respiratory tract infection frequently
requiring prolonged mechanical ventilation, sepsis, severe
renal and/or liver dysfunction, or gastrointestinal or neuro-
logical complications; and (4) late presentation with severe
reactive pulmonary hypertension. In these situations primary
repair is a high-risk procedure. Palliation with pulmonary ar-
tery banding (PAB) followed by later repair is an alternate
surgical option.9-15 PAB has been demonstrated to be
effective, particularly in the presence of advanced
pulmonary hypertension16; however, its role in infants has
always been associated with high mortality and morbidity
in the past,17 as well in recent literature.13,18
The purpose of this study was to evaluate the current role
of PAB in infants with cAVSDs, with particular focus on
outcome and its effect on the degree of atrioventricular valverdiovascular Surgery c Volume 141, Number 1 179
Abbreviations and Acronyms
cAVSD ¼ complete atrioventricular septal defect
PAB ¼ pulmonary artery banding
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Dregurgitation, both of which have been considered potential
drawbacks to PAB.17 The results of conventional PAB with
a Teflon band fixed around the pulmonary artery have been
compared with results obtained with a telemetrically adjust-
able FloWatch-PAB device (Allergan, Lausanne, Switzer-
land), which has already been successfully used in the
management of infants with atrioventricular septal defect
and other congenital heart defects.19-24MATERIALS AND METHODS
In a retrospective study we reviewed the data of 20 consecutive infants
(<1 year of age) with cAVSDs who, between 2000 and 2009, underwent
PAB instead of primary repair because of unsuitable intracardiac anatomy
(unbalanced ventricles, associated lesions, or both in 10 infants) and/or
poor clinical condition (continuous chest infections with positive infection
markers and positive cultures, despite appropriate respiratory and antibiotic
treatment, contraindicating cardiopulmonary bypass in 10 infants, with 8/10
requiring preoperative mechanical ventilation). Children older than 1 year
of age with cAVSDs with late presentation and severe pulmonary hyperten-
sion were excluded. The adjustable FloWatch-PAB device was introduced
in our institute on 2004, and surgical preference was the only determinant
between conventional PAB and FloWatch-PAB. Patients were entered in
one of the 2 groups depending on the type of PAB used. In the same period
141 patients with cAVSDs underwent complete repair. The criteria of indi-
cation for PAB instead of primary repair in 20 infants (20/161 [12%]) re-
mained the same through the study period, as did the surgical approach
(median sternotomy for all infants) and the preparation of the pulmonary ar-
tery. The only difference between the 2 groups was the use of the Teflon
band, which was premeasured according to the Trusler rule as a starting
point, in the group with conventional PAB and the implantation of the ad-
justable FloWatch-PAB device in the FloWatch-PAB group. In the conven-
tional PAB group, after the provisional fixation of the band according to the
Trusler rule, the final tightening of the band was adjusted by measuring the
distal pulmonary artery pressure and the arterial oxygen saturation. In the
FloWatch-PAB group the device, available in a single size, was simply im-
planted in a totally open position, and tightening was performed gradually
over the following days, always by means of remote control, with measure-
ment of the transband velocity with Doppler echocardiographic analysis.
Table 1 reports the characteristics of the patient population. There was no
statistical difference between the 2 groups in age and body weight. Preop-
erative mechanical ventilation was required less frequently in the conven-
tional PAB group (P< .05). Down syndrome was present in 5 (38%) of
13 infants in the conventional PAB group and 6 (86%) of 7 infants in the
FloWatch-PAB group.
Data were reviewed for (1) hospital mortality (defined as death within 30
days after the operation, in the hospital during the same admission, or in the
referring hospital when an infant was transferred back to the referring hos-
pital instead of being discharged); (2) delayed sternal closure because of he-
modynamic instability; (3) number of required PAB adjustments; (4)
duration of mechanical ventilation; (5) intensive care unit stay; (6) hospital
stay; (7) degree of atrioventricular valve regurgitation (classified as absent,
mild, moderate, or severe based on echocardiographic analysis before
surgical intervention and at last control); and (8) debanding at the time of
repair.180 The Journal of Thoracic and Cardiovascular SurgThe 2 groups were compared with paired Student’s t and c2 tests. The
retrospective study has been approved by the institutional review board.
RESULTS
Table 2 reports the observed results. A statistically signif-
icant difference between the 2 groups, conventional PAB
versus FloWatch-PAB, was observed with regard to hospital
mortality (P< .001), delayed sternal closure (P< .05),
duration of postoperative mechanical ventilation (P< .05),
duration of postoperative intensive care unit stay
(P< .05), and postoperative hospital stay (P< .05).
Cause of death was cardiorespiratory failure in 4 infants,
multiorgan failure in 2 infants, aspiration pneumonia in 1 in-
fant, and overwhelming sepsis in 1 infant; 2 infants died after
transfer back to the referral hospital, and the cause of death
remained unknown.
Five (83%) of the 6 infants with delayed sternal closure
died, with 4 of 5 requiring surgical adjustment of conven-
tional PAB with a reoperation in the intensive care unit. A
total of 44 telemetric FloWatch-PAB adjustments (41 to
tighten and 3 to release the pulmonary artery) were required
in all 7 infants in the FloWatch-PAB group (mean, 6.5 ad-
justments per patient), always by means of remote control,
with measurement of the transband velocity with Doppler
echocardiographic analysis.
The degree of left atrioventricular valve regurgitation was
unchanged in the majority of infants but increased in 2 in-
fants (mild to moderate in one and moderate to severe in
the other) in the conventional PAB group and decreased (se-
vere to moderate) in 2 infants in the FloWatch-PAB group.
Six of 10 survivors underwent pulmonary artery deband-
ing (1 in the conventional PAB group who required pulmo-
nary artery reconstruction and 5 in the FloWatch-PAB
group, none of whom required pulmonary artery reconstruc-
tion) and complete repair after a median interval of 125 days
(range, 34–871 days). Four of 10 patients are still waiting for
repair.
DISCUSSION
In the past, infants with cAVSDs were initially palliated
with PAB to prevent pulmonary vascular disease, followed
by complete repair at a later stage to reduce mortality and
morbidity.12,15 Substantial improvements in surgical and
cardiopulmonary bypass techniques, as well as perioperative
care, allowed surgeons to successfully perform early repair
of cAVSDs in infants.2-8 Nevertheless, there are situations
in which early repair in infants is not feasible or is
accompanied by unacceptable risk because of the presence
of unfavorable intracardiac anatomy (unbalanced ventricles,
associated lesions, or both) and/or poor clinical condition
(infection, chronic lung disease, or associated noncardiac
malformation). In these situations palliation with PAB
followed by late repair is recognized as a viable surgical
option.9-15ery c January 2011
TABLE 2. Results
Conventional
PAB FloWatch-PAB
Statistical
difference
Hospital deaths 10/13 (77%) 0/7 (0%) P< .001
Chest left open 6/13 (46%) 0/7 (0%) P< .05
Mechanical
ventilation, d (range)
21  17 (4–61) 3  2 (1–8) P< .05
ICU stay, d (range) 22  18 (5–61) 7  6 (2–21) P< .05
Hospital stay, d (range) 54  13 (40–71) 29  25 (9–81) P< .05
PAB, Pulmonary artery banding; ICU, intensive care unit.
TABLE 1. Patients’ characteristics
Conventional
PAB FloWatch-PAB
Statistical
difference
No. 13 7
Mean age, d (range) 74  56 (6–187) 111  40 (81–187) NS
Mean weight,
kg (range)
3.3  1.1 (2.1–5.8) 4.3  1.2 (3.2–6.1) NS
Preoperative
mechanical
ventilation
3/13 (23%) 5/7 (71%) P< .05
PAB, Pulmonary artery banding; NS, not significant.
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DPAB is usually not a low-risk procedure, particularly in
small infants. Hospital mortality of 8.6% (47/711 patients)
has been reported in the European Congenital Data-Base
(www.eactscongenitaldb.org) for all patients who
underwent isolated PAB for any congenital heart defect. A
mortality rate of 13% (12/92 patients) has been recorded
in the Society of Thoracic Surgeons Congenital Database
(www.sts.org) for isolated PAB in patients with cAVSDs,
a rate that is significantly higher than for any other
congenital heart defect. A similarly high mortality (13.
8%) has been reported in the literature for infants with
cAVSDs undergoing isolated PAB.13
In our retrospective study we observed a major difference
in mortality between the 2 groups (77% vs 0%), despite the
fact that the infants undergoing conventional PAB were gen-
erally less sick (lower incidence of a preoperative mechani-
cal ventilation and Down syndrome) than infants treated
with the adjustable FloWatch-PAB device.
We tried to analyze the reasons behind this difference in
mortality. Historically, when palliation with PAB instead of
primary repair was widely used to treat congenital heart de-
fects, the mortality with PAB was higher (59%) in infants
less than 3 months of age when compared with that seen in
infants greater than 3 months of age (21%).17 A recent
analysis of the Society of Thoracic Surgeons Congenital
Heart Database18 showed that cardiac surgery in infants
with low birth weight is associated with increased mortality.
Although there was no statistical difference in age and body
weight in our study between the conventional PAB and
FloWatch-PAB groups, we analyzed whether deaths in
the conventional PAB group occurred more frequently in
children with lower age and body weight at the time of
the operation: 7 of 10 deaths occurred in infants less than
3 months of age, and 3 of 10 deaths occurred in infants at
greater than 3 kg of body weight. In the group undergoing
conventional PAB, 9 (69%) of 13 infants were less than 3
months of age, and 5 (38%) of 13 were at less than 3 kg of
body weight versus 4 (57%) of 7 and 0 (0%) of 7, respec-
tively, in the FloWatch-PAB group. Because these differ-
ences did not reach statistical significance, younger age
and lower body weight cannot be considered risk factors
for mortality.The Journal of Thoracic and CaThe difference in mortality between the 2 groups could be
partly due to the fact that the initial group of 7 patients oper-
ated on until 2004 had been treated with conventional PAB
because the FloWatch-PAB device was not yet available.
However, the mortality with conventional PAB continued
to remain increased (50%) in the last 6 years of the study.
Because the indications for surgical intervention and the
perioperative management in infants with cAVSDs have
not changed over the study period, the surgical technique
must contribute to the difference in outcome. Additionally,
the postoperative period in the FloWatch-PAB group was
smoother, without any requirement for delayed sternal clo-
sure and shorter duration of postoperative mechanical venti-
lation and intensive care unit and hospital stay (Table 2).
These observations are similar to the results previously re-
ported with the FloWatch-PAB device in other congenital
heart defects, including preparation for Fontan circulation
in univentricular hearts and left ventricular retraining,19-24
and, in particular, when compared with conventional
PAB.21,22 The improved outcomes with the FloWatch-
PAB device appear to be the consequence of the telemetri-
cally controlled device, which allows repeated graduated
tightening of the pulmonary artery band, thereby facilitating
a controlled and stepwise reduction of the pulmonary blood
flow and pressures. The adjustments, tightening or loosen-
ing, can be tailored to the clinical condition of the patient
over a protracted period of time, ensuring a smooth early
postoperative course. In anesthetized infants it is difficult
to instantaneously achieve adequate control of pulmonary
blood flow with the application of fixed conventional PAB.
Often readjustments of the band are required, either with a re-
operation or by leaving the chest open for surgical adjust-
ments in the intensive care unit, which are associated with
a substantial risk of mortality and morbidity. The instability
of the patient’s hemodynamics, mostly caused by labile pul-
monary vascular reactivity and modifications in the left-to-
right intracardiac shunt but also related to the very delicate
balance between volume and pressure overload, make the es-
tablishment of appropriate and durable tightening extremely
difficult. This is particularly so in very sick infants with
chronic mechanical ventilation, additional lesions, or both.
The FloWatch-PAB device not only eliminates the needrdiovascular Surgery c Volume 141, Number 1 181
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Dfor reoperation to adjust the band but also provides the ability
to precisely and progressively tighten the band over days or
weeks when the patient is awake and spontaneously breath-
ing. This can be performed on the ward or outpatient clinic,
adjusting the tightening according to the clinical condition
and to the transband pressure gradient measured with Dopp-
ler echocardiographic analysis. These are the main reasons
why the FloWatch-PAB device provides better clinical
results than conventional PAB with shorter intensive care
unit and hospital stays, fewer complications, and also subse-
quent cost reduction.22
This study also confirmed an additional advantage of the
noncircular shape of the cross-section of the FloWatch-PAB
device: reconstruction of the pulmonary artery after deband-
ing is no longer required because the arterial wall remains
pliable.21 After conventional PAB, the localized fibrosis of
the pulmonary artery wall almost always requires an exten-
sive resection with patch reconstruction.
A further historical concern when considering PAB in in-
fants with cAVSDs has been the effect on atrioventricular
valve regurgitation; the total biventricular pressure overload
generated by PAB with the common atrioventricular valve
connected to both ventricles was considered a potential
cause for increasing the degree of atrioventricular valve re-
gurgitation. Our experience has demonstrated that this con-
cern is not justified. In fact, in a few infants there was
a substantial reduction in the degree of atrioventricular valve
regurgitation because of the progressive reduction in volume
overload obtained with the FloWatch-PAB device, with
a subsequent reduction in ventricular dilatation.
CONCLUSIONS
In infants with cAVSDs unsuitable for repair because of
intracardiac anatomy, high-risk clinical condition, or both,
PAB followed by late repair is a viable alternate surgical
option. The use of the adjustable FloWatch-PAB device, re-
sulting in significant hemodynamic improvement by pro-
gressively reducing the pulmonary artery pressures and the
left-to-right shunt, not only increases survival but also
makes delayed repair feasible in a better clinical state, with
reduced mortality and morbidity.
We thank Dr Tom Karl, Brisbane, Australia, for his review of the
manuscript and his comments.
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